Viking Therapeutics Inc
VKTX
$27.37+7.46%
End of day · as of Oct 16, 2026, 3:15 AM ET
Mkt cap
$3.97B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-4.67
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.69
Div yield
N/A
Sector
Healthcare
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported VKTX revenue for 2025-12-31 was $0. Net income was -$359.6M. VKTX currently screens at market cap $3.97B.
Use this VKTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VKTX income, balance, and cash tables.
Viking Therapeutics Inc (VKTX) is a biotechnology company in the Healthcare sector.
Latest cached Viking Therapeutics Inc (VKTX) net income for Dec 31, 2025 was -$359.6M. Statements: https://lician.com/financials/vktx
Viking Therapeutics Inc (VKTX) market capitalization is $3.97B on the latest cached snapshot.
Viking Therapeutics Inc (VKTX) cached previous close $25.47; day range $26.10 – $27.49; volume 5,117,351. Session quote: https://lician.com/quote/vktx
Viking Therapeutics Inc (VKTX) latest cached earnings event is "VKTX earnings" on Jul 29, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VKTX filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/vktx